Immunome Inc.: Form 8-K, filed Feb 6, 2024
Filed with the SEC on Feb 6, 2024 and accepted by EDGAR at Feb 6, 2024, 08:05 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 3.02 Unregistered sale of equity
- Item 7.01 Regulation FD disclosure
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001104659-24-010945. Last ingested by Listed: Oct 30, 2026, 12:06 ET. Listed shows no prices and gives no investment advice.